The sncRNAomics European Research Consortium, an EU-funded project that aims to use systems biology to identify the role of small non-coding RNA in infectious diseases, will use Genedata's Phylosopher software as its central data-management platform for sequencing and tiling array data.
The goal of the sncRNAomics consortium is to identify novel targets for diagnostics and therapy of five major high-risk gram-positive human microbial pathogens: Staphylococcus, Streptococcus, Enterococcus, Clostridium, and Listeria.
The researchers will use Phylosopher to integrate all experimental data from the pathogens and the host organisms.
The US Department of Energy's Joint Genome Institute has deployed more than two petabytes of Isilon scale-out network-attached storage.
Specifically, JGI is using Isilon's X-Series platform to store data from 25 genome sequencers onto a single, shared pool of storage. JGI is also using the Isilon IQ 5000S-SSD, which combines serial-attached SCSI and solid state disk drives as additional storage.
Isilon said that the new system enabled JGI to eliminate more than six disparate storage systems.
Entelos said that it has extended an existing license with Pfizer for its Metabolism Physiolab platform.
The perpetual license gives Pfizer access to Entelos' PhysioLab Modeler software and its PhysioLab Simulation Server.
Australia's Victorian Life Sciences Computation Initiative has installed an SGI Altix XE1300 cluster.
VLSCI, established by the University of Melbourne and the Victorian Government, is using the cluster to support 40 "high-profile life sciences research projects," said David Bannon, peak computing facility manager at VLSCI, in a statement.
The cluster contains 136 nodes and offers 11.5 teraflops of computing performance and 160 TB of storage.
The Barts and the London NIHR Cardiovascular Biomedical Research Unit will use IDBS InforSense Suite to analyze and visualize cardiovascular research data.
The unit, funded by a £5.45 million ($8.27 million) grant from the UK's National Institute for Health Research, will use the software to study the effects of genes on cardiovascular disease and also to examine the impact of genomic variations on disease treatment (BI 7/2/2010).